$AVD

American Vanguard (AVD) Earnings Transcript

Image source: The Motley Fool.Monday, Nov. 10, 2025 at 9 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...

Original reporting
Motley Fool · Motley Fool Transcribing, https://www.facebook.com/themotleyfool/
Published Nov 10, 2025, 2:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 11, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
American Vanguard (AVD) Earnings Transcript — source image
Decision brief

The 30-second read

$AVDNeutralLow
01

Why it matters

The earnings are unlikely to cause significant market upheaval but may influence short-term trading strategies.

02

Market read

The earnings report provides a neutral outlook for AVD, with limited immediate trading opportunities but useful for ongoing position management.

03

What to watch

Potential macroeconomic shifts or commodity price changes that could impact future performance.

Timing: short-term (next 1-2 weeks)

Background

American Vanguard operates in the agricultural chemicals sector, with recent earnings reflecting steady performance amid market uncertainties.

Company-level read

Ticker impact

$AVDNeutralMedium confidence
Context

Primary focus of the earnings transcript, relevant for short-term and long-term trading decisions.

Expected impact

Minor upward movement in the near term, potential for stabilization or slight increase over the next 1-3 months.

Evidence & confidence

The earnings report shows steady performance but lacks significant catalysts for strong price movement. Market sentiment remains neutral, and technical indicators suggest consolidation.

Market effects

Potential stabilization in the agricultural chemicals sector, with cautious optimism.

Limited regional impact, primarily affecting US-based agricultural stocks.

Minimal global market influence; sector-specific.

Counterpoint

The earnings report may be underestimating future growth potential due to emerging market opportunities.

Key entities

  • American Vanguard Corporation

    A manufacturer of crop protection chemicals and other agricultural products.

  • Motley Fool

    Source of the earnings transcript and analysis.

Related articles

$AVDMed

American Vanguard Corporation Q2 2026 Earnings Call Summary

American Vanguard reported a 10% quarterly revenue decline, driven by an 18% drop in international sales tied to Super El Nino weather and inflation in Central America and Mexico. Management cited improved gross margins (+100 bps in 1H 2026) and expects Los Angeles facility rationalization savings of at least $4M. 2026 guidance: $44M-$48M adjusted EBITDA on $530M-$550M sales.

$AVDMed

AMERICAN VANGUARD CORP (AVD): Results of Operations and Financial Condition

AMERICAN VANGUARD CORP (AVD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE American Vanguard Reports Second Quarter 2026 Results First-Half Gross Profit Increased 3%, and EBITDA Increased 21% on Mostly Flat Sales Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 mil

$AVDMedAI 8/10

American Vanguard (AVD) Q2 2026 Earnings Call Transcript

American Vanguard (AVD) reported Q2 2026 net sales of $117 million, down from $129 million in Q2 2025. International sales fell 18% in the quarter, while specialty revenue rose 11%. Adjusted EBITDA was $0.6 million versus $11 million a year earlier. 2026 guidance calls for revenue of $530 million to $550 million and adjusted EBITDA of $44 million to $48 million.

$AVDMedAI 8/10

American Vanguard Reports Second Quarter 2026 Results

American Vanguard Corporation reported Q2 2026 net sales of $117 million versus $129 million in Q2 2025, with gross margin at 30% versus 31%. The company posted an operating loss of $0.30 million and net loss of $9.9 million. Adjusted EBITDA was $6.6 million. For 2026, it reaffirmed guidance of adjusted EBITDA $44 million to $48 million on sales of $530 million to $550 million.